Making regulatory T cells with defined antigen specificity: Role in autoimmunity and cancer

Immunological Reviews

Volumn 212, Issue , 2006, Pages 163-169

  Kretschmer, Karsten ^a   Apostolou, Irina ^a   Jaeckel, Elmar ^b   Khazaie, Khashayarsha ^a   Von Boehmer, Harald ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Autoimmune suppression; Foxp3; Regulatory T cells; Transforming growth factor

Indexed keywords

CYTOKINE; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN SPECIFICITY; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; EFFECTOR CELL; HUMAN; LIGAND BINDING; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION; THYMUS; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; IMMUNOSUPPRESSION; MICE; NEOPLASMS; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 33746351318     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2006.00411.x     Document Type: Review

References (59)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
2. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.
3. + T regulatory cells. Nat Immunol 2003;4:337-342.
4. + regulatory T cells. Nat Immunol 2003;4:330-336.
5. Ohki H, Martin C, Corbel C, Coltey M, Le Douarin NM. Tolerance induced by thymic epithelial grafts in birds. Science 1987;237:1032-1035.
6. Salaun J, et al. Thymic epithelium tolerizes for histocompatibility antigens. Science 1990;247:1471-1474.
7. Modigliani Y, et al. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur J Immunol 1996;26:1807-1815.
8. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001;2:301-306.
9. + regulatory T cells in vivo. J Exp Med 2003;198:249-258.
10. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002;3:756-763.
11. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005;6:152-162.
12. Bensinger SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med 2001;194:427-438.
13. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005;6:1219-1227.
14. + regulatory T cells in human thymus. Nature 2005;436:1181-1185.
15. Gallegos AM, Beran MJ. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med 2004;200:1039-1049.
16. van Santen HM, Benoist C, Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med 2004;200:1221-1230.
17. + T cell receptors. Immunity 2004;21:267-277.
18. + T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001;167:188-195.
19. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003;101:4862-4869.
20. Chen TC, Waldmann H, Fairchild PJ. Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby. J Clin Invest 2004;113:1754-1762.
21. + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 2005;201:127-137.
22. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 2003;100:8886-8891.
23. + regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003;198:235-247.
24. + regulatory T cells in the steady state. J Exp Med 2003;198:737-746.
25. Wan YY, Flavell RA. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci USA 2005;102:5126-5131.
26. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005;22:329-341.
27. + regulatory T cells by peripheral expansion. J Immunol 2004;173:7259-7268.
28. Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004;199:1401-1408.
29. Hawiger D, Masilamani RF, Bettelli E, Kuchroo VK, Nussenzweig MC. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 2004;20:695-705.
30. Hawiger D, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001;194:769-779.
31. Bruder D, et al. On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 2005;54:3395-3401.
32. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886.
33. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004;172:5149-5153.
34. + T-cell pool and the expression of Foxp3 in vivo. Int Immunol 2004;16:1241-1249.
35. - T cells. Int Immunol 2004;16:1203-1213.
36. + T cells. J Immunol 2004;173:6526-6531.
37. + regulatory T cells. J Exp Med 2005;201:1061-1067.
38. + regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci USA 2004;101:4572-4577.
39. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000;12:431-440.
40. + regulatory T cells. J Immunol 2003;171:3348-3352.
41. Tang Q, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004;199:1455-1465.
42. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004;199:1467-1477.
43. Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 2004;104:895-903.
44. Godfrey WR, et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 2004;104:453-461.
45. + regulatory T cells suppress effector T cell proliferation. Clin Immunol 2005;115:3-9.
46. Jaeckel E, von Boehmer H, Manns MP. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005;54:306-310.
47. Allan SE, et al. The role of 2 FOXP3 isoforms in the generation of human CD4 Tregs. J Clin Invest 2005;115:3276-3284.
48. + regulatory T cells. Int Immunol 2004;16:1643-1656.
49. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005;6:1142-1151.
50. D'Cruz LM, Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 2005;6:1152-1159.
51. + regulatory T cell activity: it takes (IL-)two to tango. Eur J Immunol 2005;35:1336-1341.
52. Huehn J, et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4 regulatory T cells. J Exp Med 2004;199:303-313.
53. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
54. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
55. Chen ML, et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA 2005;102:419-424.
56. Mempel TR, et al. Regulatory T cells reversibly suppress CDS killer cell function independent of effector differentiation. Immunity (in press).
57. Fahlen L, et al. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med 2005;201:737-746.
58. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005;6:338-344.
59. Erard F, Garcia-Sanz JA, Moriggl R, Wild MT. Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CDS T cell subsets. J Immunol 1999;162:209-214.